Jean Pierre Bizzari

Insider Reports History

Location
235 Laurel Ln, Haverfold, PA
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Jean-Pierre Bizzari
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean Pierre Bizzari:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HALOZYME THERAPEUTICS, INC. Director Common Stock 66.8K $2.41M $36.00 May 5, 2023 Direct
ADC Therapeutics SA Director Common Shares 107K $383K $3.58 Jun 13, 2025 Direct
HALOZYME THERAPEUTICS, INC. Director Option to Purchase Common Stock 11.4K $158K $13.87 May 5, 2023 Direct
Aprea Therapeutics, Inc. Director Common Stock 1.05K $1.69K $1.62 Jun 5, 2025 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 5, 2025 Direct

Insider Reports Filed by Jean Pierre Bizzari

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADCT ADC Therapeutics SA Jun 13, 2025 1 -$45.1K 4 Jun 17, 2025 Director
APRE Aprea Therapeutics, Inc. Jun 5, 2025 2 $0 4 Jun 9, 2025 Director
ADCT ADC Therapeutics SA Jun 3, 2025 1 $0 4 Jun 5, 2025 Director
ADCT ADC Therapeutics SA Jun 17, 2024 1 -$20.2K 4 Jun 18, 2024 Director
ADCT ADC Therapeutics SA Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
ADCT ADC Therapeutics SA Jan 2, 2024 0 $0 3 Jan 2, 2024 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2023 1 $0 4 Aug 24, 2023 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2023 0 $0 3 Aug 24, 2023 Director
HALO HALOZYME THERAPEUTICS, INC. May 5, 2023 2 $0 4 May 9, 2023 Director
HALO HALOZYME THERAPEUTICS, INC. May 5, 2022 1 $0 4 May 6, 2022 Director
HALO HALOZYME THERAPEUTICS, INC. Aug 25, 2021 1 -$1.44M 4 Aug 25, 2021 Director